These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37580443)

  • 21. Strategies to improve PrEP uptake among West African men who have sex with men: a multi-country qualitative study.
    Reyniers T; Babo SAY; Ouedraogo M; Kanta I; Ekon Agbégnigan L; Rojas D; Eubanks A; Anoma C; Dah TTE; Mensah E; Dembélé Keita B; Spire B; Vuylsteke B; Laurent C
    Front Public Health; 2023; 11():1165327. PubMed ID: 37181706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Perceived Added Value of Bimonthly Injectable Pre-Exposure Prophylaxis According to West African Men Who Have Sex with Men: A Focus Group Study.
    Reyniers T; Fiorentino M; Babo SAY; Ouedraogo M; Kanta I; Agbegnigan LE; Rojas D; Anoma C; Dah TTE; Mensah E; Keita BD; Spire B; Vuylsteke B; Laurent C
    AIDS Patient Care STDS; 2023 Oct; 37(10):480-488. PubMed ID: 37862074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
    Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
    Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceptability of a Community-Based Outreach HIV-Testing Intervention Using Oral Fluid Collection Devices and Web-Based HIV Test Result Collection Among Sub-Saharan African Migrants: A Mixed-Method Study.
    Loos J; Manirankunda L; Platteau T; Albers L; Fransen K; Vermoesen T; Namanya F; Nöstlinger C
    JMIR Public Health Surveill; 2016 Aug; 2(2):e33. PubMed ID: 27493067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland.
    Young I; Flowers P; McDaid LM
    BMJ Open; 2014 Nov; 4(11):e005717. PubMed ID: 25412863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PrEP reminds me that I am the one to take responsibility of my life: a qualitative study exploring experiences of and attitudes towards pre-exposure prophylaxis use by women in Eswatini.
    Bjertrup PJ; Mmema N; Dlamini V; Ciglenecki I; Mpala Q; Matse S; Kerschberger B; Wringe A
    BMC Public Health; 2021 Apr; 21(1):727. PubMed ID: 33853575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acceptability of PrEP among MSM and transgender communities-Qualitative findings from two metropolitan cities in India.
    Ramanaik S; Sinha AP; Mukherjee A; Pujar A; Subramanyam K; Gopalan A; Washington R
    PLoS One; 2023; 18(2):e0281984. PubMed ID: 36812258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
    Verguet S; Stalcup M; Walsh JA
    Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding PrEP Acceptability Among Priority Populations: Results from a Qualitative Study of Potential Users in Central Uganda.
    Sundararajan R; Wyatt MA; Muwonge TR; Pisarski EE; Mujugira A; Haberer JE; Ware NC
    AIDS Behav; 2022 Aug; 26(8):2676-2685. PubMed ID: 35133529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
    Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
    BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 'We go where we know': Reflections from Mobilizing for PrEP and Sexual Health (MobPrESH) - A peer-led PrEP education programme across England, for and by women and non-binary people.
    Grenfell P; Rafael S; Calliste J; Nutland W
    Womens Health (Lond); 2022; 18():17455057221091727. PubMed ID: 35404186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa.
    Muhumuza R; Ssemata AS; Kakande A; Ahmed N; Atujuna M; Nomvuyo M; Bekker LG; Dietrich JJ; Tshabalala G; Hornschuh S; Maluadzi M; Chibanda-Stranix L; Nematadzira T; Weiss HA; Nash S; Fox J; Seeley J
    Arch Sex Behav; 2021 May; 50(4):1729-1742. PubMed ID: 33954824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spirituality/Religiosity: A Cultural and Psychological Resource among Sub-Saharan African Migrant Women with HIV/AIDS in Belgium.
    Arrey AE; Bilsen J; Lacor P; Deschepper R
    PLoS One; 2016; 11(7):e0159488. PubMed ID: 27447487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of online user discussions on Reddit associated with the transition of use between HIV PrEP therapy.
    Godinez H; Xu Q; McMann TJ; Li J; Mackey TK
    Front Public Health; 2023; 11():1073813. PubMed ID: 37457283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Emotional stress is more detrimental than the virus itself": A qualitative study to understand HIV testing and pre-exposure prophylaxis (PrEP) use among internal migrant men in South Africa.
    Nardell MF; Govathson-Mandimika C; Garnier S; Watts A; Babalola D; Ngcobo N; Long L; Lurie MN; Miot J; Pascoe S; Katz IT
    J Int AIDS Soc; 2024 Mar; 27(3):e26225. PubMed ID: 38462755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical exigencies, psychosocial realities: negotiating HIV pre-exposure prophylaxis beyond the cascade among gay, bisexual and other men who have sex with men in Canada.
    Newman PA; Guta A; Lacombe-Duncan A; Tepjan S
    J Int AIDS Soc; 2018 Nov; 21(11):e25211. PubMed ID: 30474351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers and facilitators to pre-exposure prophylaxis among African migrants in high income countries: a systematic review.
    Mwaturura C; Traeger M; Lemoh C; Stoove M; Price B; Coelho A; Mikola M; Ryan KE; Wright E
    Sex Health; 2021 May; 18(2):130-139. PubMed ID: 33658106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.
    Price JT; Wheeler SB; Stranix-Chibanda L; Hosek SG; Watts DH; Siberry GK; Spiegel HM; Stringer JS; Chi BH
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S145-53. PubMed ID: 27355502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effectiveness of tenofovir-based pre-exposure prophylaxis for prevention of HIV acquisition among sub-Saharan African women at high risk: a systematic review.
    Murewanhema G; Malisheni M; Takah NF
    Pan Afr Med J; 2021; 38():308. PubMed ID: 34178226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre-exposure prophylaxis use among HIV serodiscordant couples: a qualitative study in Mozambique.
    Sack DE; De Schacht C; Paulo P; Graves E; Emílio AM; Matino A; Fonseca CL; Aboobacar AU; Van Rompaey S; Audet CM
    Glob Health Action; 2021 Jan; 14(1):1940764. PubMed ID: 34229580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.